Here, we report the generation and performance of a NIR-tagged ELP-epidermal growth factor (ELP-EGF) fusion protein to target overexpressed EGFR in urothelial carcinoma (also known as transitional cell carcinoma, TCC) [12]. Here, EGF is linked to urothelial carcinoma.